Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Autoinflammatory syndromes associated with hidradenitis suppurativa and/or acne

Research output: Contribution to journalReviewResearchpeer-review

DOI

  1. Necrotic ulcer on the chin of a previously healthy 38-year-old woman

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. The effect of anti-IL-17 treatment on the reaction to a nickel patch test in patients with allergic contact dermatitis

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Comorbidities in vitiligo: comprehensive review

    Research output: Contribution to journalReviewResearchpeer-review

  4. Patient-reported outcomes (PROs) in chronic urticaria

    Research output: Contribution to journalReviewResearchpeer-review

  1. Atopic dermatitis is associated with increased use of social benefits: a register-based cohort study

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. The prevalence of atopic dermatitis in adults: systematic review on population studies

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Socioeconomic Costs and Health Inequalities from Psoriasis: A Cohort Study

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Omalizumab for atopic dermatitis: evidence for and against its use

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

Autoinflammatory syndromes associated with hidradenitis suppurativa (HS) and/or acne are rare but potentially debilitating disorders if not diagnosed and treated correctly. They share a common pathogenesis involving a dysregulated innate immune system with abnormal interleukin (IL)-1 signaling leading to sterile neutrophilic inflammation. The clinical features are recurrent episodes of fever, painful arthritis, and skin lesions consistent with HS, acne, and pyoderma gangrenosum (PG) accompanied by elevated systemic inflammatory markers in blood. So far, several clinically different syndromes have been reported in the literature including pyoderma gangrenosum, acne, and pyogenic arthritis (PAPA), pyoderma gangrenosum, acne, and hidradenitis suppurativa (PASH), pyoderma gangrenosum, acne, and spondyloarthritis (PASS), pyoderma gangrenosum, acne, pyogenic arthritis, and hidradenitis suppurativa (PAPASH), psoriatic arthritis, pyoderma gangrenosum, acne, and hidradenitis suppurativa (PsAPASH), and pyoderma gangrenosum, acne, and ulcerative colitis (PAC). The rarity of the syndromes complicates the establishment of evidence-based treatment guidelines. Furthermore, treatment can be challenging due to lack of response to standard treatment modalities. Therefore, it is important to increase the awareness about these diseases in order to optimize disease management and ultimately improve the quality of life of patients.

Original languageEnglish
JournalInternational Journal of Dermatology
Volume56
Issue number8
Pages (from-to)811-818
Number of pages8
ISSN0011-9059
DOIs
Publication statusPublished - Aug 2017

    Research areas

  • Journal Article, Review

ID: 52410083